$29.39
-0.49-1.64%
Últ. Act.: Nov 6, 7:58 PM
The average analyst price target for Pfizer is $30.59, 4.2% above the current price. Of 19 analysts, 7 rate it Buy, 10 Hold and 2 Sell. Targets range from $25 to $45. The latest change came on Nov 6, 2026, when Freedom Broker raised its price target on Pfizer from $33 to $34 and kept a Buy rating.
Price Target Range — 13 Quarters
Analyst Consensus — 19 Analysts
Rating Trend — Last 9 Months